Antibiotics of Pharma API Neomycin Sulfate CAS No.: 1405-10-3

• Customization: Available
• CAS No.: 1405-10-3
• Formula: C23h48n6o17s
• Model NO.: hanways01
• EINECS: 215-773-1
• Type: Pharmaceutical Intermediates
• Appearance: Powder
• Quality: Crude
• Colour: White
• Transport Package: 25kg/Drum
• Specification: 99%min
• Trademark: hanways
• Origin: China
• Production Capacity: 500kg/Month

Product Description

Sodium2,3-dimercapfo8propanesulf- onate Monohydrate (DMPS) cas no.: 207233-91-8


PRODUCT DETALS

Items	Specifications	Result
Description, appearance	White powder or white-crystalline powdler.	white-crystalline powdler.
Solubility	Freely soluble in water, almost non-solublein 95% of Ethanol, aether or	Conform
IdentificationA	Conform	Conform
IdentificationB	Conform	Conform
IdentificationC	Conform	Conform
Solution colority	Conform	Conform
Loss on drying	6.5-8.5%	7.9%
Heavy metals	Pb: Not more than 10ppm	7.4ppm
Residue on ignition (Cauteranttemperature less than  600ºC)	30.5-33.0%	30.9%
Substance related	Total impurities ≤5.0%	3.2%
Residual solvent	Ethanol: Not more than 0.5%	0.01%
	Aetic acid: Not more than 0.5%	N.D
Assay	C3H7NAO3S3, not less than 98.0%,calculatedon the dried basis.	N.D
Conlusion	The product is tested qualifiedly according to Enterprise Internal Standard.	98.6%

 

 

THERAPEUTIC INDICATIONS

The drug for the treatment of hair loss dwindled.
Finasteride is used to treat symptoms of BPH such as frequent and difficult urination and may reduce the chance of acute urinary retention (sudden inability to urinate). It also may decrease the chance that prostate surgery will be needed.

SHIPPING DETAILS
 

MOQ	50G
BY air	Any airport in china
By sea	Any seaport in china
By courier	/

ABOUT US 
HANWEISHI PHARMCHEM CO., LTD. is an import and export company located in Wuhan, which providing comprehensive supply solution for our customers in pharmaceutical and nutraceutical industries. We supply APIs, pharmaceutical intermediates, excipients, natural extracts, and food and feed additives. Our service also includes conducting manufacture audit, applying for regulatory registration, and contract manufacturing.
Since established in 2007, Hanways has developed long term strategic relationships with major manufacturers in China, including Zhejiang Xianju Pharmaceutical Co., Ltd, Zhejiang Guobang Pharmaceutical Co., Ltd and more than 100 others.
HANWEISHI is actively exploring the international market, as well as participating the world CPhI. Nowadays we already have a large number of customers in Southeast Asia, Mid-East, Central and South America, East Europe and African countries.